Dr Sami A Rizvi, MD | |
6271 Green Field Rd # D-l3, Elkridge, MD 21075-6263 | |
(301) 852-3768 | |
Not Available |
Full Name | Dr Sami A Rizvi |
---|---|
Gender | Male |
Speciality | General Practice |
Location | 6271 Green Field Rd # D-l3, Elkridge, Maryland |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1811583982 | NPI | - | NPPES |
CV2005333 | Other | IN | INDIANA LICENSE |
NJDCATEMP-033509 | Other | NJ | NJ :LICENSE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | NJDCATEMP-033509 (New Jersey) | Secondary |
208D00000X | General Practice | CV2005333 (Indiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Sami A Rizvi, MD 6271 Green Field Rd # D-l3, Elkridge, MD 21075-6263 Ph: (301) 852-3768 | Dr Sami A Rizvi, MD 6271 Green Field Rd # D-l3, Elkridge, MD 21075-6263 Ph: (301) 852-3768 |
News Archive
Geisinger Medical Center will participate in ProTECT III, a groundbreaking National Institute of Health -sponsored research study for the emergency treatment of traumatic brain injuries using the hormone progesterone.
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced it has submitted a New Drug Application (NDA) for Lymphoseek to the U.S. Food and Drug Administration.
The trillions of bacteria in your digestive system play a major role in your metabolism, and they're linked to your risks of type 2 diabetes, obesity and the related conditions that make up "metabolic syndrome," which has become a global health epidemic.
In a small study of opioid prescriptions filled at a Johns Hopkins Medicine outpatient pharmacy, researchers found that handwritten orders for the drugs contribute heavily to a trio of prescribing and processing errors in contrast to those created electronically.
MT Services LLC, a Lawsuit Settlement News Reporting Company which operates lawsuitsettlementnews.com, announced today that Takeda Pharmaceutical Co.'s $2.37 billion settlement over their diabetes drug Actos is going through and moving forward. Actos drug maker, Takeda, agreed to toss in another $100 million if enough claimants signed up with matching settlement criteria – 97% of the claims to be exact.
› Verified 8 days ago
Virendra V Chhunchha, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 6653 Hunter Rd, Elkridge, MD 21075 Phone: 410-796-3745 | |
Dr. Marie Luise Bergmeyer, D0 General Practice Medicare: Medicare Enrolled Practice Location: 6755 Old Waterloo Rd Apt 316, Elkridge, MD 21075 Phone: 917-669-3731 |